Difference in virulence between Neisseria meningitidis serogroups W and Y in transgenic miceShow others and affiliations
2020 (English)In: BMC Microbiology, ISSN 1471-2180, E-ISSN 1471-2180, Vol. 20, no 1, article id 92
Article in journal (Refereed) Published
Abstract [en]
BACKGROUND: Neisseria meningitidis serogroups W and Y are the most common serogroups causing invasive meningococcal disease in Sweden. The majority of cases are caused by the serogroup W UK 2013 strain of clonal complex (cc) 11, and subtype 1 of the serogroup Y, YI strain of cc23. In this study, virulence factors of several lineages within cc11 and cc23 were investigated in transgenic BALB/c mice expressing human transferrin. Transgenic mice were infected intraperitoneally with serogroup W and Y isolates. Levels of bacteria and the proinflammatory cytokine CXCL1 were determined in blood collected 3 h and 24 h post-infection. Apoptosis was investigated in immune cells from peritoneal washes of infected mice. Adhesion and induction of apoptosis in human epithelial cells were also scored.
RESULTS: The levels of bacteraemia, CXCL1, and apoptosis were higher in serogroup W infected mice than in serogroup Y infected mice. Serogroup W isolates also induced higher levels of apoptosis and adhesion in human epithelial cells. No significant differences were observed between different lineages within cc11 and cc23.
CONCLUSIONS: N. meningitidis Serogroup W displayed a higher virulence in vivo in transgenic mice, compared to serogroup Y. This was reflected by higher bacteremia, proinflammatory activity, and ability to induce apoptosis in mouse immune cells and human epithelial cells.
Place, publisher, year, edition, pages
BioMed Central, 2020. Vol. 20, no 1, article id 92
Keywords [en]
Neisseria meningitidis, Serogroup W, Serogroup Y, Transgenic mice, Virulence
National Category
Infectious Medicine
Identifiers
URN: urn:nbn:se:oru:diva-81345DOI: 10.1186/s12866-020-01760-4ISI: 000528725400001PubMedID: 32295520Scopus ID: 2-s2.0-85083478167OAI: oai:DiVA.org:oru-81345DiVA, id: diva2:1427288
Note
Funding Agencies:
Örebro County Council Research Committee
Nyckelfonden, Örebro University Hospital, Örebro, Sweden
Institut Pasteur, Paris, France
Örebro University
2020-04-292020-04-292020-12-01Bibliographically approved